Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-05-18FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for memantine hydrochloride from Actavis Pharma, Inc.
-
FDA approval · 2016-04-19FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for galantamine from Aurobindo Pharma Limited, enabling continued market approval as a generic optio…
-
FDA approval · 2016-04-19FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for galantamine hydrobromide from Sun Pharmaceutical Industries, Inc. under an ANDA, granting author…
-
FDA approval · 2016-04-11FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (Kreitchman PET Center)
The FDA approved Fludeoxyglucose F18 through an Original Application filed by Kreitchman PET Center for use as a radiopharmaceutical in PET …
-
FDA approval · 2016-04-07FDA Approved: VIZAMYL — Supplemental Application (GE Healthcare Inc. (Medi-Physics, Inc. dba GE Healthcare))
FDA approves a supplemental application for Vizamyl (flutemetamol F-18) from GE Healthcare. The approval updates the product labeling to ref…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-03-25FDA Approved: RIVASTIGMINE TARTRATE — Original Application (Aurobindo Pharma Limited)
FDA approved an original generic application for rivastigmine tartrate from Aurobindo Pharma Limited, enabling a generic version of rivastig…
-
FDA approval · 2016-03-09FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for AMYVID (Florbetapir F-18) submitted by Eli Lilly. This action confirms continued regulatory …
-
FDA approval · 2016-03-08FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (FLORBETABEN F 18) from Lantheus Biosciences Ltd.
-
FDA approval · 2016-03-07FDA Approved: MEMANTINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for memantine hydrochloride submitted by Actavis Pharma, Inc. under NDA. The action finalizes ch…
-
FDA approval · 2016-02-26FDA Approved: FLUDEOXYGLUCOSE F 18 — Supplemental Application (Massachusetts General Hospital)
FDA approved a supplemental application for Fludeoxyglucose F-18 submitted by Massachusetts General Hospital to support its use as a radioph…
-
FDA approval · 2016-02-19FDA Approved: MEMANTINE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for memantine submitted by NorthStar RxLLC (ANDA090048).
-
FDA approval · 2016-02-19FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Edenbridge Pharmaceuticals LLC.)
The FDA approved Edenbridge Pharmaceuticals LLC's generic donepezil hydrochloride product (Original Application), making a generic version o…
-
FDA approval · 2016-01-25FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (Florbetaben F-18) by Lantheus Biosciences Ltd., supporting its use as a PET imaging ag…
-
FDA approval · 2015-12-01FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for donepezil hydrochloride submitted by ScieGen Pharmaceuticals, Inc., authorizing changes to t…
-
FDA approval · 2015-11-30FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Ajanta Pharma USA Inc.)
FDA approved the original application for memantine hydrochloride from Ajanta Pharma USA Inc., allowing marketing of a generic memantine pro…
-
FDA approval · 2015-11-20FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for a generic donepezil hydrochloride product manufactured by Solco Healthcare US, LLC.
-
FDA approval · 2015-11-17FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for rivastigmine tartrate submitted by Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-11-17FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for rivastigmine tartrate from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-11-17FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for galantamine hydrobromide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2015-11-17FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for rivastigmine tartrate submitted by Alembic Pharmaceuticals Limited.
-
FDA approval · 2015-10-30FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (3D Imaging Drug Design and Development LLC)
FDA approved Fluorodeoxyglucose F18 (FDG F-18) as an original radiopharmaceutical for PET imaging to assess metabolic activity in oncology, …
-
FDA approval · 2015-10-30FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' generic donepezil hydrochloride (ANDA original application) for the treatment of mild, moderate, and sev…
-
FDA approval · 2015-10-27FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Kettering Medical Center)
FDA approved Fludeoxyglucose F-18 (FDG F-18) under an Original Application by Kettering Medical Center for use as a PET imaging radiopharmac…
-
FDA approval · 2015-10-26FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for galantamine submitted by Aurobindo Pharma Limited.
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved memantine hydrochloride from Alembic Pharmaceuticals Limited under an original ANDA.